Abstract
Purpose
Sweeteners are common in the human diet under different physiological conditions. Using a rat model of scopolamine-induced amnesia, this study aimed to compare the neuroinflammatory effects of sucrose (caloric) and aspartame (non-caloric), two popular sweeteners in Nigeria beverages and non-alcoholic drinks.
Methods
The study used male Wistar rats that were separated into six groups: a control group, a scopolamine group, and two additional groups that received scopolamine combined with either sucrose or aspartame at varying concentrations estimated from common beverages and non-alcoholic drinks in Nigeria (low and high consumption). All sweeteners were administered to the treatment groups once daily for 14 days, while the control group received distilled water. On days 12 and 14, scopolamine was administered. Thereafter, tumour necrosis factor-alpha (TNF-α), activities of adenosine deaminase (ADA), arginase, and acetylcholinesterase (AChE), as well as immunohistochemical analysis of glial fibrillary acidic protein (GFAP) and ionic calcium binding adaptor molecule 1 (IBA1), were determined in the brain cortex and hippocampus.
Results
Results showed that both sucrose and aspartame either maintained or aggravated the impairments caused by scopolamine in both the cortex and hippocampus. Particularly in the hippocampus, sucrose significantly aggravated the scopolamine-induced elevated TNF-α and reduced arginase and acetylcholinesterase activities, while in the cortex, sucrose aggravated scopolamine-induced elevated TNF-α and GFAP reactivity, while reducing ADA activity. On the other hand, aspartame aggravated Iba1 reactivity in the cortex.
Conclusion
In conclusion, at estimated levels found in common beverages and nonalcoholic drinks in Nigeria, both for low and high consumers, both sucrose and aspartame, and particularly aspartame, aggravated indices of neuroinflammation in the scopolamine-induced amnesic rat model. Consequently, these sweeteners may not be advisable under amnesic conditions. However, considering the limitations of animal studies, further studies, particularly clinical evaluations in humans, are highly encouraged.
Similar content being viewed by others
Data availability
Data associated with this study is available through the corresponding author upon reasonable request.
References
Ashwell M, Gibson S, Bellisle F, Buttriss J, Drewnowski A, Fantino M, Gallagher AM, De Graaf K, Goscinny S, Hardman CA, Laviada-Molina H. Expert consensus on low-calorie sweeteners: facts, research gaps and suggested actions. Nutr Res Rev. 2020;33(1):145–54.
Tou JC, Fitch C, Bridges K. Sweeteners: Uses, dietary intake and health effects. Chocolate, fast foods and sweeteners: consumption and health. Bishop MR. Nova Science Publishers, Inc. 2011:1–28.
Rippe JM. The health implications of sucrose, high-fructose corn syrup, and fructose: What do we really know? J Diabetes Sci Technol. 2010;4(4):1008–11.
Fitch C, Keim KS. Position of the Academy of Nutrition and Dietetics: Use of Nutritive and Nonnutritive Sweeteners...[corrected] [published erratum appears in J ACAD NUTR DIET 2012; 112(8):1279]. J Acad Nutr Diet. 2012;112(5):739–58.
White JS. Straight talk about high-fructose corn syrup: What it is and what it ain’t. Am J Clin Nutr. 2008;88(6):1716S-1721S.
Johnson RJ, Sánchez-Lozada LG, Andrews P, Lanaspa MA. Perspective: A historical and scientific perspective of sugar and its relation with obesity and diabetes. Adv Nutr. 2017;8(3):412–22.
Pistollato F, Iglesias RC, Ruiz R, Aparicio S, Crespo J, Lopez LD, et al. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies. Pharmacol Res. 2018;131:32–43.
Mastroeni D, Nolz J, Sekar S, Delvaux E, Serrano G, Cuyugan L, et al. Laser-captured microglia in the Alzheimer’s and Parkinson’s brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer’s brain. Neurobiol Aging. 2018;63:12–21.
Brouns F. Guideline: Sugars intake for adults and children. Geneva: World Health Organization; 2015. (Agro Food Ind Hi Tech. (2015)).
Gardner C, Wylie-Rosett J, Gidding SS, Steffen FLM, Johnson FRK, Reader D, et al. Nonnutritive sweeteners: Current use and health perspectives - A scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2012;126(4):509–19.
Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MP. Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity. 2008;16(8):1894–900.
Lenoir M, Serre F, Cantin L, Ahmed SH. Intense sweetness surpasses cocaine reward. PLoS One. 2007;2(8):e698.
Balaban H, Nazıroğlu M, Demirci K, Övey İS. The protective role of selenium on scopolamine-induced memory impairment, oxidative stress, and apoptosis in aged rats: the involvement of TRPM2 and TRPV1 channels. Mol Neurobiol. 2017;54(4):2852–68.
Demirci K, Nazıroğlu M, Övey İS, Balaban H. Selenium attenuates apoptosis, inflammation and oxidative stress in the blood and brain of aged rats with scopolamine-induced dementia. Metab Brain Dis. 2017;32(2):321–9.
Wong-Guerra M, Jiménez-Martin J, Pardo-Andreu GL, Fonseca-Fonseca LA, Souza DO, de Assis AM, et al. Mitochondrial involvement in memory impairment induced by scopolamine in rats. Neurol Res. 2017;39(7):649–59.
Akinyemi AJ, Oboh G, Oyeleye SI, Ogunsuyi O. Anti-amnestic effect of curcumin in combination with donepezil, an anticholinesterase drug: involvement of cholinergic system. Neurotox Res. 2017;31(4):560–9.
Odubanjo VO, Ibukun EO, Oboh G, Adefegha SA. Aqueous extracts of two tropical ethnobotanicals (Tetrapleura tetraptera and Quassia undulata) improved spatial and non-spatial working memories in scopolamine-induced amnesic rats: Influence of neuronal cholinergic and antioxidant systems. Biomed Pharmacother. 2018;99:198–204.
Sigala S, Imperato A, Rizzonelli P, Casolini P, Missale C, Spano PF. L-α-glycerylphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eur J Pharmacol. 1992;211(3):351–8.
Gutierres JM, Carvalho FB, Schetinger MRC, Rodrigues MV, Schmatz R, Pimentel VC, et al. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats. Life Sci. 2012;91(23–24):1221–8.
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659–61.
Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27.
Oboh G, Ogunsuyi OB, Olonisola OE. Does caffeine influence the anticholinesterase and antioxidant properties of donepezil? Evidence from in vitro and in vivo studies. Metab Brain Dis. 2017;32(2):629–39.
Czarnecka K, Pilarz A, Rogut A, Maj P, Szymańska J, Olejnik Ł, et al. Aspartame—true or false? Narrative review of safety analysis of general use in products. Nutrients. 2021;13(6):1957.
Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1–2):248–54.
Oboh G, Adebayo AA, Ademosun AO, Olowokere OG. Rutin alleviates cadmium-induced neurotoxicity in Wistar rats: involvement of modulation of nucleotide-degrading enzymes and monoamine oxidase. Metab Brain Dis. 2019;34(4):1181–90.
Kepka-Lenhart D, Ash DE, Morris SM. Determination of mammalian arginase activity. Methods in enzymology. 2008;440:221–30.
Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88–95.
Akinyemi AJ, Okonkwo PK, Faboya OA, Onikanni SA, Fadaka A, Olayide I, et al. Curcumin improves episodic memory in cadmium induced memory impairment through inhibition of acetylcholinesterase and adenosine deaminase activities in a rat model. Metab Brain Dis. 2017;32(1):87–95.
Erukainure OL, Ijomone OM, Sanni O, Aschner M, Islam MS. Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine. Metab Brain Dis. 2019;34(5):1385–99.
Ijomone OM, Nwoha PU. Nicotine inhibits hippocampal and striatal acetylcholinesterase activities, and demonstrates dual action on adult neuronal proliferation and maturation. Pathophysiology. 2015;22(4):231–9.
Sharma A, Amarnath S, Thulasimani M, Ramaswamy S. Artificial sweeteners as a sugar substitute: Are they really safe?. Indian journal of pharmacology. 2016 May;48(3):237.
Tandel KR. Sugar substitutes: Health controversy over perceived benefits. J Pharmacol Pharmacother. 2011;2(4):236–43.
Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157–72.
Novoa C, Salazar P, Cisternas P, Gherardelli C, Vera-Salazar R, Zolezzi JM, Inestrosa NC. Inflammation context in Alzheimer’s disease, a relationship intricate to define. Biol Res. 2022;55(1):1–8.
Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer’s disease. A&D Transl Res Clin Interv. 2018;4(1):575–90.
Calovi S, Mut-Arbona P, Sperlágh B. Microglia and the purinergic signaling system. Neuroscience. 2019;405:137–47.
D’Ambrosio C, Cigliano L, Mazzoli A, Matuozzo M, Nazzaro M, Scaloni A, et al. Fructose Diet-associated molecular alterations in hypothalamus of adolescent rats: a proteomic approach. Nutrients. 2023;15(2):475.
Hsu TM, Konanur VR, Taing L, Usui R, Kayser BD, Goran MI, et al. Effects of sucrose and high fructose corn syrup consumption on spatial memory function and hippocampal neuroinflammation in adolescent rats. Hippocampus. 2015;25(2):227–39.
Schmitt LO, Gaspar JM. Obesity-Induced brain neuroinflammatory and mitochondrial changes. Metabolites. 2023;13(1):86.
Srivastava P, Tripathi PN, Sharma P, Rai SN, Singh SP, Srivastava RK, et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Eur J Med Chem. 2019;163:116–35.
Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, Zengin G, Mathew B, Shah MA, Arora S. Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated Parkinson’s disease. Current Neuropharmacology. 2021;19(2):233–47.
Sauer AV, Hernandez RJ, Fumagalli F, Bianchi V, Poliani PL, Dallatomasina C, Riboni E, Politi LS, Tabucchi A, Carlucci F, Casiraghi M. Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients. Scientific reports. 2017;7(1):40136.
Wei CJ, Li W, Chen JF. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2011;1808(5):1358–79.
Whitmore KV, Gaspar HB. Adenosine deaminase deficiency–more than just an immunodeficiency. Frontiers in immunology. 2016;7:314.
Schiano C, Grimaldi V, Scognamiglio M, Costa D, Soricelli A, Nicoletti GF, et al. Soft drinks and sweeteners intake: Possible contribution to the development of metabolic syndrome and cardiovascular diseases Beneficial or detrimental action of alternative sweeteners? Food Res Int. 2021;142:110220.
Gajecki D, Gawryś J, Szahidewicz-Krupska E, Doroszko A. Role of erythrocytes in nitric oxide metabolism and paracrine regulation of endothelial function. Antioxidants. 2022;11(5):943.
Ren Y, Li Z, Li W, Fan X, Han F, Huang Y, et al. Arginase: biological and therapeutic implications in diabetes mellitus and its complications. Oxid Med Cell Longev. 2022;2022:1–20.
Pandya CD, Lee B, Toque HA, Mendhe B, Bragg RT, Pandya B, et al. Age-dependent oxidative stress elevates arginase 1 and uncoupled nitric oxide synthesis in skeletal muscle of aged mice. Oxid Med Cell Longev. 2019;2019:1–9.
Xiong Y, Yepuri G, Necetin S, Montani JP, Ming XF, Yang Z. Arginase-II promotes tumor necrosis factor-α release from pancreatic acinar cells causing β-cell apoptosis in aging. Diabetes. 2017;66(6):1636–49.
Yang Z, Ming XF. Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol. 2013;4:149.
Kang GG, Trevaskis NL, Murphy AJ, Febbraio MA. Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH. iScience. 2023;26(1):105905.
Polis B, Samson AO. Arginase as a potential target in the treatment of Alzheimer’s disease. Adv Alzheimer’s Dis. 2018;7(4):119–40.
Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–12.
Kiranmai M. Consumption of artificial sweeteners: boon or bane. International Journal of Pharmacy. 2016;6:94–98.
Becker SL, Chiang E, Plantinga A, Carey H V., Suen G, Swoap SJ. Effect of stevia on the gut microbiota and glucose tolerance in a murine model of diet-induced obesity. FEMS Microbiol Ecol. 2020;96(6):fiaa079.
Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Obstet Gynecol Surv. 2015;70(1):31–2.
Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y, Chen S, Lin X, Zhang G, Xiao H, Dong B. Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging. Front Immunol. 2022;13:796288.
Rai SN, Singh C, Singh A, Singh MP, Singh BK. Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer’s disease. Mol Neurobiol. 2020;57(7):3075–88.
Sochocka M, Donskow-Łysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease—a critical review. Mol Neurobiol. 2019;56(3):1841–51.
Chong CP, Shahar S, Haron H, Che Din N. Habitual sugar intake and cognitive impairment among multi-ethnic malaysian older adults. Clin Interv Aging. 2019;14:1331–42.
Freeman CR, Zehra A, Ramirez V, Wiers CE, Volkow ND, Wang GJ. Impact of sugar on the body, brain, and behavior. Front Biosci (Landmark edition). 2018;23(12):2255–66.
Brites D, Monteiro M, Ribeiro AR, Cunha C, Vaz AR, Fernandes A. Role of neuron-microglia secretome and stress-related microRNAS in Alzheimer’s disease. InGLIA. 2017;65:E301–E302.
Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol. 2016;53(2):1181–94.
Tripathi PN, Srivastava P, Sharma P, Tripathi MK, Seth A, Tripathi A, et al. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem. 2019;85:82–96.
David B, Schneider P, Schäfer P, Pietruszka J, Gohlke H. Discovery of new acetylcholinesterase inhibitors for Alzheimer’s disease: virtual screening and in vitro characterisation. J Enzyme Inhib Med Chem. 2021;36(1):491–6.
Tyagi E, Agrawal R, Nath C, Shukla R. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain. Eur J Pharmacol. 2010;640(1–3):206–10.
Gutierres VO, Pinheiro CM, Assis RP, Vendramini RC, Pepato MT, Brunetti IL. Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. Br J Nutr. 2012;108(3):440–8.
Acknowledgements
The authors acknowledge the support of International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and Alzheimer’s Association.
Funding
None.
Author information
Authors and Affiliations
Contributions
B.C. and O.B. came up with the concept for the study. S.T. carried out the bench work with input from O.B. The histopathology experiments were carried out in O. M.'s lab, while other bench work was done in G.O.'s lab. The data was gotten and recorded by S.T., after which it was curated by O.B. and B.C. The results were given a thorough review by all the authors, after which a manuscript was developed by O. P. This manuscript was first reviewed by the corresponding author (O.B.) after which all other authors reviewed the manuscript and sent it out for publication.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The handling and use of the animals were in accordance with institutional ethical guide for the care and use of laboratory animals under ethical approval FUTA/ETH/21/20.
Competing interests
The authors declare no competing interests.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Babatunde, O.O., Christiana, A.B., Sunday, O.I. et al. Comparative effect of selected caloric and non-caloric sweeteners on some neuroinflammatory indices in brain cortex and hippocampus of scopolamine-induced rat. Nutrire 49, 13 (2024). https://doi.org/10.1186/s41110-024-00254-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s41110-024-00254-x